Skip to main content
Merck KGaA logo

Merck KGaA — Investor Relations & Filings

ISIN · DE0006599905 LEI · 529900OAREIS0MOPTW25 Manufacturing
Open in API
Filings indexed 131 across all filing types
Latest filing 2012-04-02 Annual Report
Country DE Germany
Listing —

About Merck KGaA

https://www.merckgroup.com/

Merck KGaA is a global science and technology company operating through three primary business sectors: Healthcare, Life Science, and Electronics. The Healthcare division focuses on discovering, developing, and manufacturing prescription medicines for conditions such as oncology, multiple sclerosis, and infertility. The Life Science business provides researchers with laboratory tools, technologies, and services to facilitate scientific breakthroughs and biopharmaceutical manufacturing. The Electronics sector develops high-tech materials and solutions for the semiconductor and display industries. Driven by a long history of innovation, the company integrates specialized expertise to address complex global challenges, offering a diverse portfolio of products ranging from life-saving therapies to advanced materials that power modern digital infrastructure.

Recent filings

Filing Released Lang Actions
Annual Report 2011
Annual Report Classification · 100% confidence The document is titled 'Merck Annual Report 2011' and contains detailed sections typical of an annual report, including a letter to shareholders, group management report, corporate governance, consolidated financial statements, auditor's report, and notes to the accounts. It covers the full fiscal year 2011 and includes comprehensive financial data and analysis. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2011
2012-04-02 English
Annual Report 2011
Annual Report Classification · 100% confidence The document is titled 'Merck Annual Report 2011' and contains detailed sections typical of an annual report, including a letter to shareholders, group management report, corporate governance, consolidated financial statements, auditor's report, and extensive financial and operational data for the fiscal year 2011. The length is substantial (15,000 characters), and the content includes comprehensive financial figures, management discussion, and corporate information. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K). FY 2011
2012-03-30 English
Q3 Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive 'Quarterly Financial Report' for Merck for the period ending September 30, 2011 (Q3 2011). It contains detailed financial statements (Income Statement, Balance Sheet, Cash Flow Statement), an Interim Management Report, segment reporting, and notes to the financial statements. It is not an announcement or a summary, but the full interim report itself, fitting the definition of an Interim/Quarterly Report (IR). Q3 2011
2011-11-01 English
Q2 Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half-Year Financial Report' and references the period ending June 30, 2011, indicating it covers a half-year period. It contains detailed financial statements such as income statement, balance sheet, cash flow statement, segment reporting, and notes to the interim financial statements. It also includes a management report section with business highlights, risk report, expected developments, and detailed financial analysis. The length is substantial (15,000 characters), and the content includes actual financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2011
2011-07-27 English
Q1 Report 2011
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Financial Report' for Merck for the period ending March 31, 2011. It contains comprehensive financial statements (Income Statement, Balance Sheet, Cash Flow Statement), an Interim Management Report, and detailed segment reporting. It is not an earnings release (which would be a summary) nor a report publication announcement (as it contains the full report content). Therefore, it is classified as an Interim/Quarterly Report. Q1 2011
2011-04-28 English
Annual Report 2010
Annual Report Classification · 100% confidence The document is titled 'ANNUAL REPORT 2010' for Merck and contains extensive content typical of an annual report, including a letter from the CEO, management report, corporate governance, consolidated financial statements, auditor's report, and detailed financial data for the fiscal year 2010. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of comprehensive financial statements and management discussion confirms it is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2010
2011-03-29 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.